Palvella Therapeutics (PVLA) Earnings Date, Estimates & Call Transcripts $46.51 +1.87 (+4.19%) As of 02:50 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Palvella Therapeutics Earnings Summary Palvella Therapeutics posted Q2 2025 earnings on August 14, 2025, reporting an EPS of -$0.86, which missed the consensus estimate of -$0.78 by $0.08. With a trailing EPS of -$12.10, Palvella Therapeutics' earnings are expected to grow next year, from ($3.69) to ($2.77) per share. Latest Q2 Earnings DateAug. 14EstimatedConsensus EPS (Aug. 14) -$0.78 Actual EPS (Aug. 14) -$0.86 Missed By -$0.08 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Palvella Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Palvella Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPVLA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Palvella Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$3.56-$3.56-$3.56Q2 20252-$3.79-$0.77-$2.28Q3 20252-$4.05-$0.81-$2.43Q4 20252-$4.33-$0.81-$2.57 Palvella Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025-$0.78-$0.86 -$0.08-$0.86--5/15/2025Q1 2025-$3.40-$0.74+$2.66-$0.74-- Palvella Therapeutics Earnings - Frequently Asked Questions When is Palvella Therapeutics' earnings date? Palvella Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on PVLA's earnings history. Did Palvella Therapeutics beat their earnings estimates last quarter? In the previous quarter, Palvella Therapeutics (NASDAQ:PVLA) missed the analysts' consensus estimate of ($0.78) by $0.08 with a reported earnings per share (EPS) of ($0.86). Learn more on analysts' earnings estimate vs. PVLA's actual earnings. How can I listen to Palvella Therapeutics' earnings conference call? The conference call for Palvella Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Palvella Therapeutics' conference call transcript? The conference call transcript for Palvella Therapeutics' latest earnings report can be read online. Read Transcript How much profit does Palvella Therapeutics generate each year? Palvella Therapeutics (NASDAQ:PVLA) has a recorded net income of -$17.43 million. PVLA has generated -$12.10 earnings per share over the last four quarters. What is Palvella Therapeutics' EPS forecast for next year? Palvella Therapeutics' earnings are expected to grow from ($3.69) per share to ($2.77) per share in the next year. More Earnings Resources from MarketBeat Related Companies TWST Earnings Date SRPT Earnings Date IMCR Earnings Date BHVN Earnings Date AUPH Earnings Date JANX Earnings Date DYN Earnings Date TVTX Earnings Date EWTX Earnings Date SDGR Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Brinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings Beat This page (NASDAQ:PVLA) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Palvella Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Palvella Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access